Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Alliance Opposes PE, Modifier 25 Proposals in CY 2027 Medicare Physician Fee Schedule September 1, 2026
Specialty Docs Provide Feedback on Medicare Provider Enrollment Proposals August 21, 2026
Alliance Supports Legislation to Modernize the Medicare Physician Fee Schedule August 7, 2026
Alliance Voices Strong Concerns over OMB Federal Financial Assistance Rule July 13, 2026© 2026 Alliance of Specialty Medicine. All rights reserved. Website designed and developed by Orpheus, Inc..

